0
$0.00

AOD9604

Product Overview Of AOD9604

  • Goals: Fat loss, metabolic support, joint and cartilage health
  • Administration: 300 mcg–500 mcg subcutaneously, daily (research settings)
  • Cycle Length: 4–12 weeks
  • Note: A modified fragment of human growth hormone (HGH) designed for fat metabolism without IGF-1 activation

AOD-9604 is a peptide fragment of human growth hormone studied for its potential to enhance fat loss, support metabolic health, and promote joint repair in research settings across Canada.

$109.99

Get Notified

Coming Early 2026!

Share On Social!

Reviews For AOD9604 From Helixx Online

[users_name][users_handle]
[users_review]
[users_name][users_handle]
[users_review]
[users_name][users_handle]
[users_review]
[users_name][users_handle]
[users_review]
[users_name][users_handle]
[users_review]

What is AOD-9604?

AOD-9604 is a synthetic peptide derived from the C-terminal fragment of human growth hormone (HGH). Unlike HGH, it does not activate IGF-1, meaning it may support fat metabolism without the anabolic side effects of full growth hormone. Originally developed for its potential in obesity management, AOD-9604 is now being studied for fat loss, metabolic regulation, and joint health applications.

How Does AOD-9604 Work?

AOD-9604 stimulates the breakdown of stored fat by enhancing lipolysis (fat breakdown) and inhibiting lipogenesis (fat accumulation). By mimicking the effects of growth hormone on adipose tissue without influencing blood sugar or growth factors, it may provide a targeted pathway for fat metabolism. Research also indicates possible benefits in cartilage repair and inflammation reduction.

Chemical Properties

Chemical Name AOD-9604
CAS Number 221231-10-3
Molecular Formula C78H123N23O23S2
Molecular Weight 1815.1 g/mol
Peptide Sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Gly-Ser-Cys-Gly-Phe

Potential Benefits of AOD-9604

  • Fat Loss: Promotes lipolysis and reduces new fat storage.
  • Metabolic Support: Studied for improving weight management without affecting blood glucose.
  • Joint & Cartilage Health: May aid cartilage repair and reduce inflammation.
  • Non-Anabolic: Designed to avoid IGF-1 or growth-promoting activity.

Clinical Research & Findings

Research on AOD-9604 suggests it may accelerate fat metabolism while maintaining stable glucose levels. Animal studies and early clinical trials indicate a potential role in obesity treatment, metabolic syndrome, and cartilage repair. Unlike HGH, it does not stimulate muscle growth, making it a more specialized compound in metabolic and orthopedic research.

Dosage & Research Protocols

  • Research Dose: 300–500 mcg per day (subcutaneous)
  • Cycle Length: Typically 4–12 weeks

Administration is most often subcutaneous. Longer-term studies may explore its cumulative impact on fat loss and joint health.

FAQs

Is AOD-9604 legal in Canada?

Yes. AOD-9604 is legal for research use in Canada but not approved for human consumption.

How does AOD-9604 differ from HGH?

AOD-9604 is a fragment of HGH designed to target fat metabolism without activating IGF-1 or promoting muscle growth.

Does AOD-9604 help with fat loss?

Research indicates it may enhance fat breakdown while reducing fat storage, making it a candidate for weight management studies.

What form does AOD-9604 come in?

AOD-9604 is provided in lyophilized powder form with ≥98% purity for laboratory research use.

Disclaimer

For laboratory use only. Not for human or veterinary use.

This peptide is intended strictly for research under controlled laboratory conditions. Buyers are responsible for ensuring legal and ethical compliance with institutional, local, and federal regulations.


0